These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 33748158)

  • 1. Validation of the REVEAL Prognostic Models in Systemic Lupus Erythematosus-Associated Pulmonary Arterial Hypertension.
    Qu J; Li M; Zeng X; Zhang X; Wei W; Zuo X; Zhu P; Ye S; Zhang W; Zheng Y; Qi W; Li Y; Zhang Z; Ding F; Gu J; Liu Y; Zhang M; Qian J; Huang C; Zhao J; Wang Q; Liu Y; Tian Z; Wang Y
    Front Med (Lausanne); 2021; 8():618486. PubMed ID: 33748158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of the REVEAL Prognostic Equation and Risk Score Calculator in Incident Systemic Sclerosis-Associated Pulmonary Arterial Hypertension.
    Mullin CJ; Khair RM; Damico RL; Kolb TM; Hummers LK; Hassoun PM; Steen VD; Mathai SC;
    Arthritis Rheumatol; 2019 Oct; 71(10):1691-1700. PubMed ID: 31066998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prognostic model for systemic lupus erythematosus-associated pulmonary arterial hypertension: CSTAR-PAH cohort study.
    Qu J; Li M; Zhang X; Zhang M; Zuo X; Zhu P; Ye S; Zhang W; Zheng Y; Qi W; Li Y; Zhang Z; Ding F; Gu J; Liu Y; Qian J; Huang C; Zhao J; Wang Q; Liu Y; Tian Z; Wang Y; Wei W; Zeng X
    Respir Res; 2023 Sep; 24(1):220. PubMed ID: 37689662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The REVEAL Registry risk score calculator in patients newly diagnosed with pulmonary arterial hypertension.
    Benza RL; Gomberg-Maitland M; Miller DP; Frost A; Frantz RP; Foreman AJ; Badesch DB; McGoon MD
    Chest; 2012 Feb; 141(2):354-362. PubMed ID: 21680644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting the Risk of Pulmonary Arterial Hypertension in Systemic Lupus Erythematosus: A Chinese Systemic Lupus Erythematosus Treatment and Research Group Cohort Study.
    Qu J; Li M; Wang Y; Duan X; Luo H; Zhao C; Zhan F; Wu Z; Li H; Yang M; Xu J; Wei W; Wu L; Liu Y; You H; Qian J; Yang X; Huang C; Zhao J; Wang Q; Leng X; Tian X; Zhao Y; Zeng X
    Arthritis Rheumatol; 2021 Oct; 73(10):1847-1855. PubMed ID: 34105259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk assessment in systemic lupus erythematosus-associated pulmonary arterial hypertension: CSTAR-PAH cohort study.
    Wang Q; Qian J; Li M; Zhang X; Wei W; Zuo X; Zhu P; Ye S; Zhang W; Zheng Y; Qi W; Li Y; Zhang Z; Ding F; Gu J; Liu Y; Huang C; Zhao J; Liu Y; Tian Z; Wang Y; Zhang M; Zeng X
    Ther Adv Chronic Dis; 2022; 13():20406223221112528. PubMed ID: 35898921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of two predictive models for survival in pulmonary arterial hypertension.
    Sitbon O; Benza RL; Badesch DB; Barst RJ; Elliott CG; Gressin V; Lemarié JC; Miller DP; Muros-Le Rouzic E; Simonneau G; Frost AE; Farber HW; Humbert M; McGoon MD
    Eur Respir J; 2015 Jul; 46(1):152-64. PubMed ID: 25837032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and Validation of an Abridged Version of the REVEAL 2.0 Risk Score Calculator, REVEAL Lite 2, for Use in Patients With Pulmonary Arterial Hypertension.
    Benza RL; Kanwar MK; Raina A; Scott JV; Zhao CL; Selej M; Elliott CG; Farber HW
    Chest; 2021 Jan; 159(1):337-346. PubMed ID: 32882243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence and survival impact of pulmonary arterial hypertension among patients with systemic lupus erythematosus: a nationwide cohort study.
    Chen HA; Hsu TC; Yang SC; Weng CT; Wu CH; Sun CY; Lin CY
    Arthritis Res Ther; 2019 Mar; 21(1):82. PubMed ID: 30917868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary arterial hypertension in systemic lupus erythematosus based on a CSTAR-PAH study: Baseline characteristics and risk factors.
    Zhang N; Li M; Qian J; Wang Q; Zhao J; Yang Z; Tian Z; Zhang X; Zuo X; Zhang M; Zhu P; Ye S; Zhang W; Zheng Y; Qi W; Li Y; Zhang Z; Ding F; Gu J; Liu Y; Wei W; Zeng X
    Int J Rheum Dis; 2019 May; 22(5):921-928. PubMed ID: 30746850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary Arterial Hypertension Associated With Systemic Lupus Erythematosus: Results From the French Pulmonary Hypertension Registry.
    Hachulla E; Jais X; Cinquetti G; Clerson P; Rottat L; Launay D; Cottin V; Habib G; Prevot G; Chabanne C; Foïs E; Amoura Z; Mouthon L; Le Guern V; Montani D; Simonneau G; Humbert M; Sobanski V; Sitbon O;
    Chest; 2018 Jan; 153(1):143-151. PubMed ID: 28851621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary hypertension on systemic sclerosis-lupus erythematosus overlap syndrome.
    Rachdi I; Tougorti M; Daoud F; Aydi Z; Zoubeidi H; Ben Dhaou B; Boussema F
    Ann Cardiol Angeiol (Paris); 2019 Oct; 68(4):221-225. PubMed ID: 30685083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting Survival in Patients With Pulmonary Arterial Hypertension: The REVEAL Risk Score Calculator 2.0 and Comparison With ESC/ERS-Based Risk Assessment Strategies.
    Benza RL; Gomberg-Maitland M; Elliott CG; Farber HW; Foreman AJ; Frost AE; McGoon MD; Pasta DJ; Selej M; Burger CD; Frantz RP
    Chest; 2019 Aug; 156(2):323-337. PubMed ID: 30772387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical characteristics and prognosis in systemic lupus erythematosus-associated pulmonary arterial hypertension based on consensus clustering and risk prediction model.
    Dai M; Zhang C; Li C; Wang Q; Gao C; Yue R; Yao M; Su Z; Zheng Z
    Arthritis Res Ther; 2023 Aug; 25(1):155. PubMed ID: 37612772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival and prognostic factors of systemic lupus erythematosus-associated pulmonary arterial hypertension: A PRISMA-compliant systematic review and meta-analysis.
    Qian J; Wang Y; Huang C; Yang X; Zhao J; Wang Q; Tian Z; Li M; Zeng X
    Autoimmun Rev; 2016 Mar; 15(3):250-7. PubMed ID: 26640159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retrospective Validation of the REVEAL 2.0 Risk Score With the Australian and New Zealand Pulmonary Hypertension Registry Cohort.
    Anderson JJ; Lau EM; Lavender M; Benza R; Celermajer DS; Collins N; Corrigan C; Dwyer N; Feenstra J; Horrigan M; Keating D; Kermeen F; Kotlyar E; McWilliams T; Rhodes B; Steele P; Thakkar V; Williams T; Whitford H; Whyte K; Weintraub R; Wrobel JP; Keogh A; Strange G
    Chest; 2020 Jan; 157(1):162-172. PubMed ID: 31563497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting survival in pulmonary arterial hypertension: insights from the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL).
    Benza RL; Miller DP; Gomberg-Maitland M; Frantz RP; Foreman AJ; Coffey CS; Frost A; Barst RJ; Badesch DB; Elliott CG; Liou TG; McGoon MD
    Circulation; 2010 Jul; 122(2):164-72. PubMed ID: 20585012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe pulmonary arterial hypertension secondary to lupus in the emergency department: proactive intense care associated with a better short-term survival.
    Chen Y; Guo L; Li Y; Chen GL; Chen XX; Ye S
    Int J Rheum Dis; 2015 Mar; 18(3):331-5. PubMed ID: 24946184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term prognosis of patients with systemic lupus erythematosus-associated pulmonary arterial hypertension: CSTAR-PAH cohort study.
    Qian J; Li M; Zhang X; Wang Q; Zhao J; Tian Z; Wei W; Zuo X; Zhang M; Zhu P; Ye S; Zhang W; Zheng Y; Qi W; Li Y; Zhang Z; Ding F; Gu J; Liu Y; Wang Y; Zeng X;
    Eur Respir J; 2019 Feb; 53(2):. PubMed ID: 30635295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does the SORG Algorithm Predict 5-year Survival in Patients with Chondrosarcoma? An External Validation.
    Bongers MER; Thio QCBS; Karhade AV; Stor ML; Raskin KA; Lozano Calderon SA; DeLaney TF; Ferrone ML; Schwab JH
    Clin Orthop Relat Res; 2019 Oct; 477(10):2296-2303. PubMed ID: 31107338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.